コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 by monocyte-derived macrophages (both M1 and M2 macrophages).
2 red due to low binding affinity of M2pep for M2 macrophage.
3 age chemoattraction and differentiation into M2 macrophage.
4 s of chemokine mRNA and increased numbers of M2 macrophages.
5 e for mTORC2 signalling in the generation of M2 macrophages.
6 reduction in apoptotic M1, but not apoptotic M2 macrophages.
7 Administration of IL-4 is known to augment M2 macrophages.
8 ytokines and chemokines in the M1 versus the M2 macrophages.
9 chment in markers of alternatively activated M2 macrophages.
10 0-fold higher in M1 macrophages than that in M2 macrophages.
11 hage content and an enrichment in markers of M2 macrophages.
12 mmatory M1 macrophages and anti-inflammatory M2 macrophages.
13 by selective induction of anti-inflammatory M2 macrophages.
14 can program naive monocytes to polarize into M2 macrophages.
15 d a concomitant enhancement in arginase-1(+) M2 macrophages.
16 immune evasion by establishing residency in M2 macrophages.
17 and oxidative metabolism, characteristic of M2 macrophages.
18 tes, polarizing them toward tumor-supporting M2 macrophages.
19 No such trends were observed for CD163+ M2 macrophages.
20 out major effects on alternatively activated M2 macrophages.
21 to do so in the interleukin 4 (IL4)-induced M2 macrophages.
22 r cells (MDSCs), and alternatively activated M2 macrophages.
23 eported for AM HC-HA-PTX3 on polarization of M2 macrophages.
24 tases with the exception of CD4+ T cells and M2 macrophages.
25 +)/IL-31(+) macrophages and CD68(+)/CD163(+) M2 macrophages.
26 myeloid-derived suppressor cells (MDSC), and M2 macrophages.
27 TNF-alpha levels were 5x higher with M1 vs. M2 macrophages.
28 in macrophage gene expression in both M1 and M2 macrophages.
29 d a significant reduction of pro-tumorigenic M2 macrophages.
30 1 inhibitor 3887 suppresses SPM formation in M2 macrophages.
31 nds of the spectrum are classified as M1 and M2 macrophages.
32 cytic capacity than alternatively activated (M2) macrophages.
33 gh the induction of alternatively activated (M2) macrophages.
34 ors reduce leukotrienes in M1 but less so in M2 macrophages, 3) zileuton blocks resolution-initiating
35 is, together with disturbed proportion of M1/M2 macrophages, accompanied by enhanced formation of art
37 d direct-acting antiviral therapy attenuated M2 macrophage activation and associated liver fibrosis.
39 (OVA), we investigated Th2 immune responses, M2 macrophage activation and skin barrier gene expressio
40 icular fungal species in the gut and promote M2 macrophage activation at distant sites to influence s
41 ccompanied by a shift toward pro-tumorigenic M2 macrophage activation in Slc7a2-deficient mice, as ma
43 The combined effect of restrained M1 and M2 macrophage activation resulted in decreased productio
51 sociated with alternative anti-inflammatory (M2) macrophage activation, including interleukin 4 (IL-4
52 components related to interferon activation, M2 macrophages, adaptive immunity, extracellular matrix
55 ected mice lacking A2BAR exhibited decreased M2 macrophage and eosinophil recruitment and reduced IL-
56 ment, differential expression between M1 and M2 macrophages and a validation using genes causing mono
57 ificantly increased levels of protumorigenic M2 macrophages and beta-cateninSer552 (beta-CatSer552) e
59 SDF-1 expressing cells, HGF expressing Ym1+ M2 macrophages and CD133+ stem cells in the injury sites
64 t model showed reduction of tumor-associated M2 macrophages and favored polarization towards an antit
65 in accumulation of inflammation-suppressing M2 macrophages and FOXP3(+) Tregs in plaques and reduced
67 sponse, mediated by a decrease of protumoral M2 macrophages and increased infiltration of antitumor C
69 ic tumor microenvironment that harbored more M2 macrophages and myeloid-derived suppressor cells.
70 mice that had a depleted ability to develop M2 macrophages and other in-vitro studies supported that
71 ct and selective depletion of protumorigenic M2 macrophages and promotes antitumor immunity, highligh
72 inhibitor-loaded nanoparticles (DNTs) target M2 macrophages and simultaneously inhibit CSF1R and SHP2
73 ation of eosinophils, but markedly decreased M2 macrophages and SPEM features, while eosinophil deple
76 ermore, we demonstrated that the decrease in M2 macrophages and TAMs, concomitant with the reduction
77 apable of downregulating the M2 phenotype in M2 macrophages and that the low expression of this miRNA
78 atment increased parasympathetic modulation, M2 macrophages and the anti-oxidant enzyme activity but
79 ethally infected mice showed polarization of M2 macrophages and their accumulation in peritoneum, but
82 d in reduced infiltration of protumorigenic (M2) macrophages and dramatically decreased ascites volum
83 mmune cells such as alternatively activated (M2) macrophages and Th17 cells play a role in the progre
85 to 1664 +/- 349 cells/mg; P < 0.01), M1 and M2 macrophages, and dendritic cells in perivascular adip
86 s of pro-tumorigenic alternatively polarized M2 macrophages, and lower levels of several chemokines a
87 umulation of regulatory T cells, mast cells, M2 macrophages, and markedly elevated transforming growt
88 ting effector T cells, increases a subset of M2 macrophages, and significantly prolongs survival in c
89 T cells as well as alternatively activated (M2) macrophages, and the induction of pulmonary histopat
92 The polarization processes for M1 versus M2 macrophages are quite distinct in the context of chan
95 stimulated naive monocytes to polarize into M2 macrophages as indicated by increased surface express
96 sion associated with alternatively activated M2 macrophages as well as expression of genes associated
97 in the PDL-tail and were mainly produced by M2 macrophages at the early stage and by activated myofi
99 ediates colonic homeostasis by modulating M1/M2 macrophage balance and preventing extensive dysbiosis
100 tions to improve our understanding of the M1-M2 macrophage balance and properly exploit it in tissue
101 mopoietic phenotype of increased circulating M2 macrophages but failed to affect plaque development.
102 A restricted the proliferation of protumoral M2 macrophages but increased the proliferation of antitu
103 containing liposomes killed activated murine M2 macrophages, but not Hut78 cells, demonstrating selec
104 12+ colon mesenchymal cells (CMCs) generated M2 macrophages by regulating their shape during recovery
108 ant perivascular infiltration of M1, but not M2, macrophages coincides with endothelial expression of
111 and contribute to the pathology of obesity, M2 macrophages contribute to the pathology of asthma, bu
114 only increased levels of CCL18, a marker of M2 macrophages, correlate with low CD4+ T cell counts in
115 ammatory M1 to alternative anti-inflammatory M2 macrophages, could potentially display osteoclast-lik
116 red via enhanced levels of anti-inflammatory M2 macrophages coupled with an impaired sensitivity of s
118 ecific loss of TRPC3 showed that M1, but not M2 macrophages, deficient in Trpc3 are less susceptible
120 han M2pepKLA to primary, bone marrow-derived M2 macrophage, desired selectivity was retained only wit
123 and more glycolytic M1 phenotype, but not to M2 macrophage differentiation, which primarily relies on
128 Collectively, these results suggest that M2 macrophages directly reduce the levels of HSV-1 laten
130 HA induces FoxP3 T regulatory cells in vivo, M2 macrophages drive transforming growth factor-beta and
132 investigated, T regulatory cells and M0 and M2 macrophages emerged as the most strongly associated w
135 ess was established by transferring purified M2 macrophages from PAM3 treated control donors into DSS
136 ction has also been described, as well as in M2 macrophage function under defined circumstances.
137 were increased in GF-fed offspring, as were M2 macrophage gene markers and tight junction-related ge
138 e proinflammatory M1 macrophages induce T1D, M2 macrophages have been shown to delay this autoimmune
139 EPS induces development of anti-inflammatory M2 macrophages in a TLR4-dependent manner, and these cel
146 , consistent with a key role of arginase and M2 macrophages in myeloma elimination by Th2 cells.
147 ed the origin and functional requirement for M2 macrophages in regression in normolipidemic mice that
151 ting the immune response toward either M1 or M2 macrophages in vivo, wild-type mice were injected wit
152 pro-inflammatory (M1) and anti-inflammatory (M2) macrophages in human breast adipose tissue, determin
154 lls, increased M1 macrophages, and decreased M2 macrophages, indicating that host Wnt5a promotes an i
156 CM) from M1 macrophages, but not from M0 and M2 macrophages, induced chemokine (C-X-C motif) ligand 1
157 eneic CD4(+) T cell activation, but promotes M2 macrophage-induced autologous and allogeneic CD4(+) T
158 These results suggest a critical role for M2 macrophage induction in chronic HCV-associated immune
160 T helper type 2-skewed immune polarization, M2 macrophage infiltration, and endothelial-to-mesenchym
161 T helper type 2-skewed immune polarization, M2 macrophage infiltration, and endothelial-to-mesenchym
162 They also exhibited more adipogenesis with M2 macrophage infiltration, both of which were abolished
165 ment of both eosinophils and IL33-expressing M2 macrophages into corpus tissues were evident in SAMP.
167 nt downstream infiltration of IL33-producing M2 macrophages leading to intestinalized SPEM in SAMP, s
168 C. innocuum stimulates tissue remodeling via M2 macrophages, leading to an adipose tissue barrier tha
169 on, and in liver sections, PRMT1, c-Myc, and M2 macrophage levels were strongly correlated with each
171 CVc inhibits phagocytosis activity of M1 and M2 macrophages, M1 macrophage-induced autologous and all
172 Treatment with the CM from CYP4A10(high) M2 macrophages (M2) increased pre-metastatic niche forma
173 Cs suppressed cytokine production, increased M2 macrophage marker expression, and augmented phagocyti
174 diated upregulation of the anti-inflammatory M2 macrophage marker interleukin-4Ralpha (IL-4Ralpha).
175 hage marker, was decreased; while Cd206, the M2 macrophage marker, was increased in skeletal muscle o
177 iNos, Ip10) and promoting the expression of M2 macrophage markers (Mrc1, Arg1, Il10) in bone-marrow-
178 exhibited the lower levels of ER stress and M2 macrophage markers than those from cGVHD-affected mic
179 thin the brain and an elevated expression of M2 macrophage markers than those receiving cryptococcal-
181 hages polarize in local environments, M1 and M2 macrophages may coexist in different organs and may d
182 Gpr132 expression positively correlates with M2 macrophages, metastasis, and poor prognosis in patien
183 The seemingly opposing functions of M1 and M2 macrophages must be tightly regulated for an effectiv
184 shed an immunosuppressive milieu mediated by M2 macrophages, myeloid-derived suppressor cells, CD1d(h
185 ophages are chemotactic to chemerin, whereas M2 macrophages not expressing ChemR23 surface receptor a
187 y in the ICU is associated with an increased M2 macrophage number, increased vascular density, and an
189 ived monocytes and "alternatively activated" M2 macrophages obtained by interleukin 4 treatment, but
192 o nonstimulated conditions (M0), addition of M2 macrophages, or no macrophage addition (P < 0.05), su
193 was associated with greater infiltration of M2 macrophages (p = 0.011) and neutrophils (p = 0.055).
194 Furthermore, VEGFC administration reduced M2 macrophage pericystic infiltrate, which has been impl
195 macrophages by 4.6% (P = 0.07), whereas the M2 macrophage phenotype increased by 46.9% (P = 0.04).
196 mor-associated macrophages (TAMs) exhibit an M2 macrophage phenotype that suppresses anti-tumor immun
198 omplex, which promotes the anti-inflammatory M2 macrophage phenotype, and assists TRXR1-regulated arr
199 ppression and miR-146a induction promote the M2 macrophage phenotype, resulting in amelioration of ac
202 in human proinflammatory M1 and proresolving M2 macrophage phenotypes that, upon exposure to Escheric
206 that reparative (alternatively activated or M2) macrophages play a role in repair of damaged tissues
207 inhibitors aspirin and celecoxib suppressed M2 macrophage polarization and decreased allergic airway
208 of colonic homeostasis caused by aberrant M1/M2 macrophage polarization and dysbiosis contributes to
213 TSP-2 knockdown induced anti-inflammatory M2 macrophage polarization at 21 d; however, it did not
214 tion of gp130 signaling leads to a defective M2 macrophage polarization followed by exacerbated infla
216 tion, enhanced type 2 cytokine signaling and M2 macrophage polarization in the subcutaneous white fat
219 we examined the expression profile of 16 M1/M2 macrophage polarization markers at 3 h and 7 d postin
221 Obesity shifts the immune phenotype from M2 macrophage polarization to M1, which causes metabolic
222 , lower aortic valve leaflet area, increased M2 macrophage polarization, and improved echocardiograph
223 es the activation of key pathways leading to M2 macrophage polarization, including STAT3, STAT6, Krup
224 lular communication and pro-tumoral baseline M2 macrophage polarization, the Panc-1 cells were transf
225 d spare respiratory capacity, and induced an M2 macrophage polarization-associated gene profile.
234 increases regulatory T cells which activate M2 macrophages, prevent T cell proliferation and reduce
238 tors, enhanced vascularity, and decreased M1/M2 macrophage ratios may account for the enhanced tumori
239 D8(+) T-cell infiltration, (iii) enhanced M1/M2 macrophage ratios, (iv) inhibited tumor growth, (v) b
241 T cells, Ly6C(+) monocytes, and both M1 and M2 macrophages; reduced tubulointerstitial and glomerula
242 phages primarily rely on glycolysis, whereas M2 macrophages rely on the tricarboxylic acid cycle and
244 1 macrophages are highly glycolytic, whereas M2 macrophages require a more oxidative nutrient metabol
246 ns revealed an increase in anti-inflammatory M2 macrophage responses in liver and spleen, as associat
248 ation of any cytotoxic drug cargo, exhibited M2 macrophage-selective toxicity not observed in monoval
249 ariants were associated with UM risk; M1 and M2 macrophage-specific gene expression was associated wi
251 id A (SAA) are significantly up-regulated in M2 macrophages stimulated with IL-31, but not in IL-4 re
252 n, confocal staining for macrophages, M1 and M2 macrophage subtypes, alpha-actin, and DAPI was perfor
254 ocytose tumor cells, while anti-inflammatory M2 macrophages such as tumor-associated macrophages (TAM
255 ytes to differentiate into immunosuppressive M2 macrophages, suggesting that PAM3 might be of benefit
256 e cold-induced recruitment of adipose tissue M2 macrophages, suggesting the role of CSF1R signaling i
259 s, PCTR1 levels were significantly higher in M2 macrophages than in M1 phenotype, along with members
260 xpressed inducible NO synthase and decreased M2 macrophages that expressed Arginase 1 and were found
261 , with concomitant enhancements in ILC2s and M2 macrophages that helped control adipose tissue inflam
262 rgistic activation of Arg1 by RA and IL-4 in M2 macrophages that involves feed forward regulation of
263 ymphoid cells, which promote polarization of M2 macrophages, thereby enhancing expansion of the Treg
264 0.6 cells/visual field; p < 0.05, n = 6) and M2 macrophages [though the infiltration of macrophages w
265 its monocyte differentiation to either M1 or M2 macrophages through TLR2, associated with impaired ST
266 This results in efficient repolarization of M2 macrophages to an active M1 phenotype, and superior p
267 ge arginase-1 is the only factor required by M2 macrophages to block T cells in G1, and this effect i
270 ytokines and chemokines, converted bystander M2 macrophages to M1, upregulated antigen presentation m
271 not resting (M0) or alternatively activated (M2) macrophages, to prime resting autologous NK cells.
272 et for 12 weeks showed increased circulating M2 macrophages together with a reduction in plaque forma
275 g in vivo and in vitro studies, we show that M2 macrophages trigger hepatocyte senescence and enhance
276 effects were associated with an increase of M2 macrophages (twice in relation to control animals) an
277 pulmonary type 2 immune response (Th2 cells, M2 macrophages, type 2 innate lymphoid cells, IL-33, IL-
278 n and bioenergetics of in vitro models, with M2 macrophages utilizing oxidative phosphorylation (OX P
279 ionship between duration of stay in the ICU, M2 macrophages, vascularization, and pancreatic cell rep
280 irect, selective depletion of protumorigenic M2 macrophages via attenuation of CSF1 receptor signalin
282 l field; p < 0.01, n = 6), the percentage of M2 macrophages was decreased (denervated vs intact: 31 +
284 RalphaKO mice, a marked reduction of uterine M2-macrophages was detected, a cell type relevant for an
285 CSF-1 DNA, which enhances the development of M2 macrophages, was associated with reduced virus replic
286 (-/-) phenotype was in part due to increased M2 macrophages, we adoptively transferred wt macrophages
287 and selective binding of [M2pep]2-Biotin to M2 macrophages were achieved with at least 10-fold lower
292 of Th1/Th17 cells and the polarization of M1/M2 macrophages; whereas the systemic immune responses ap
293 umor edge causing proliferative expansion of M2 macrophages, which in turn promotes tumor growth.
294 ed to controls with a reciprocal decrease in M2 macrophages, which remained unchanged among pathologi
295 r molecule Rictor inhibits the generation of M2 macrophages while leaving the generation of classical
297 y defined by the balance between M0, M1, and M2 macrophages, with distinct survival patterns by ER st
298 the 32 tested cytokines and chemokines than M2 macrophages, with HSV-1 infection significantly incre
299 focal histology demonstrated a prevalence of M2 macrophages within the aortic medium in mice treated
300 ng obese mice exhibited greater ratios of M1/M2 macrophages within the peritoneal and visceral adipos